Solution reagent kit IVD0058

diagnosticfor RT-PCRliquid

The kit is a qualitative in vitro nucleic acid amplification assay to detect and differentiate SARS-CoV-2, influenza A virus (IFV A), and influenza B virus (IFV B) in oropharyngeal swab specimen from individuals suspected of respiratory viral infection consistent with COVID-19, suspicious clustering cases and those under investigation. This test uses a similar lab setting and procedure when compared to our SARS-CoV-2 detection assay. Advantages: ★ Highly sensitive – Superior limit of detection ★ Highly specific – No cross-reactivity with human genome and 50 human respiratory pathogens ★ High-scalability – Ramp up testing capacity with 96-well plates ★ Easy to use – All-inclusive with pre-mixed reagents